Losartan-Induced Hypotension Leads to Tau Hyperphosphorylation and Memory Deficit-Reference-Cited by-同舟云学术

Losartan-Induced Hypotension Leads to Tau Hyperphosphorylation and Memory Deficit

Published:2014-03-31 Issue:2 Volume:40 Page:419-427
ISSN:1875-8908
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Liu Xinghua¹,Wang Zhihong²,Xia Yiyuan¹,Yu Guang¹,Zeng Kuan¹,Luo Hongbin¹,Hu Jichang¹,Gong Cheng-Xin¹³,Wang Jian-Zhi¹,Zhou Xin-Wen¹,Wang Xiao-Chuan¹

Affiliation:

1. Department of Pathophysiology, Key Laboratory of Neurological Disease of National Education Ministry, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

2. Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

3. Department of Neurochemistry, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, NY, USA

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Augmentation of the EPR effect by mild hyperthermia to improve nanoparticle delivery to the tumor;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-07

2. The Emerging Evidence for a Protective Role of Fucoidan from Laminaria japonica in Chronic Kidney Disease-Triggered Cognitive Dysfunction;Marine Drugs;2022-04-07

3. Potential role of Drug Repositioning Strategy (DRS) for management of tauopathy;Life Sciences;2022-02

4. Drug repositioning and repurposing for Alzheimer disease;Nature Reviews Neurology;2020-09-16

5. Antihypertensive agents in Alzheimer’s disease: beyond vascular protection;Expert Review of Neurotherapeutics;2019-12-27